|
|
|
Home > Pharmaceuticals & Biotechnology |
|
|
|
|
Pharmaceuticals & Biotechnology Market Research Reports |
Johnson & Johnson: Performance, Capabilities, Goals and Strategies in the Worldwide Pharmaceutical Market
A strategic assessment of Johnson & Johnson, one of the world's leading pharmaceutical companies, provides significant competitor information, analysis, and insight critical to the development and implementation of effective marketing and R&D programs. The report presents a comprehensive analysis of the company's performance, capabilities, goals and strategies in the global pharmaceutical market.Contains 103 pages and 8 tables
|
|
|
$1900.00 |
|
|
|
|
Merck: Performance, Capabilities, Goals and Strategies in the Worldwide Pharmaceutical Market
A strategic assessment of Merck, one of the world's leading pharmaceutical companies, provides significant competitor information, analysis, and insight critical to the development and implementation of effective marketing and R&D programs. The report presents a comprehensive analysis of the company's performance, capabilities, goals and strategies in the global pharmaceutical market.Contains 99 pages and 8 tables
|
|
|
$1900.00 |
|
|
|
|
Novartis: Performance, Capabilities, Goals and Strategies in the Worldwide Pharmaceutical Market
A strategic assessment of Novartis, one of the world's leading pharmaceutical companies, provides significant competitor information, analysis, and insight critical to the development and implementation of effective marketing and R&D programs. The report presents a comprehensive analysis of the company's performance, capabilities, goals and strategies in the global pharmaceutical market.Contains 140 pages and 11 tables
|
|
|
$1900.00 |
|
|
|
|
Pfizer: Performance, Capabilities, Goals and Strategies in the Worldwide Pharmaceutical Market
A strategic assessment of Pfizer, one of the world's leading pharmaceutical companies, provides significant competitor information, analysis, and insight critical to the development and implementation of effective marketing and R&D programs. The report presents a comprehensive analysis of the company's performance, capabilities, goals and strategies in the global pharmaceutical market.Contains 117 pages and 7 tables
|
|
|
$1900.00 |
|
|
|
|
Roche: Performance, Capabilities, Goals and Strategies in the Worldwide Pharmaceutical Market
A strategic assessment of Roche, one of the world's leading pharmaceutical companies, provides significant competitor information, analysis, and insight critical to the development and implementation of effective marketing and R&D programs. The report presents a comprehensive analysis of the company's performance, capabilities, goals and strategies in the global pharmaceutical market.Contains 112 pages and 11 tables
|
|
|
$1900.00 |
|
|
|
|
Sanofi-Aventis: Performance, Capabilities, Goals and Strategies in the Worldwide Pharmaceutical Market
A strategic assessment of Sanofi-Aventis, one of the world's leading pharmaceutical companies, provides significant competitor information, analysis, and insight critical to the development and implementation of effective marketing and R&D programs. The report presents a comprehensive analysis of the company's performance, capabilities, goals and strategies in the global pharmaceutical market.Contains 97 pages and 8 tables
|
|
|
$1900.00 |
|
|
|
|
Wyeth: Performance, Capabilities, Goals and Strategies in the Worldwide Pharmaceutical Market
A strategic assessment of Wyeth, one of the world's leading pharmaceutical companies, provides significant competitor information, analysis, and insight critical to the development and implementation of effective marketing and R&D programs. The report presents a comprehensive analysis of the company's performance, capabilities, goals and strategies in the global pharmaceutical market.Contains 65 pages and 7 tables
|
|
|
$1900.00 |
|
|
|
|
Eli Lilly: Performance, Capabilities, Goals and Strategies in the Worldwide Pharmaceutical Market
A strategic assessment of Eli Lilly, one of the world�s leading pharmaceutical companies, provides significant competitor information, analysis, and insight critical to the development and implementation of effective marketing and R&D programs. The report presents a comprehensive analysis of the company�s performance, capabilities, goals and strategies in the global pharmaceutical marketContains 65 pages and 7 tables.
|
|
|
$1900.00 |
|
|
|
|
Abbott: Performance, Capabilities, Goals and Strategies in the Worldwide Pharmaceutical Market
A strategic assessment of Abbott, one of the world's leading pharmaceutical companies, provides significant competitor information, analysis, and insight critical to the development and implementation of effective marketing and R&D programs. The report presents a comprehensive analysis of the company's performance, capabilities, goals and strategies in the global pharmaceutical market. Contains 90 pages and 8 tables
|
|
|
$1900.00 |
|
|
|
|
Lanxess: Performance, Capabilities, Goals and Strategies in the Worldwide Life Science Intermediates Market
A strategic assessment of Bayer/Lanxess, one of the world's leading life science intermediates companies, provides significant competitor information, analysis, and insight critical to the development and implementation of effective marketing and R&D programs. The report presents a comprehensive analysis of the company's performance, capabilities, goals, and strategies in the global life science intermediates market.Contains 43 pages and 7 tables
|
|
|
$1900.00 |
|
|
|
|
Cambrex: Performance, Capabilities, Goals and Strategies in the Worldwide Life Science Intermediates Market
A strategic assessment of Cambrex, one of the world's leading life science intermediates companies, provides significant competitor information, analysis, and insight critical to the development and implementation of effective marketing and R&D programs. The report presents a comprehensive analysis of the company's performance, capabilities, goals, and strategies in the global life science intermediates market.Contains 56 pages and 9 tables
|
|
|
$1900.00 |
|
|
|
|
Clariant: Performance, Capabilities, Goals and Strategies in the Worldwide Life Science Intermediates Market
A strategic assessment of Clariant, one of the world's leading life science intermediates companies, provides significant competitor information, analysis, and insight critical to the development and implementation of effective marketing and R&D programs. The report presents a comprehensive analysis of the company's performance, capabilities, goals, and strategies in the global life science intermediates market.Contains 41 pages and 5 tables
|
|
|
$1900.00 |
|
|
|
|
DowPharma: Performance, Capabilities, Goals and Strategies in the Worldwide Life Science Intermediates Market
A strategies assessment of DowPharma, one of the world's leading life science intermediates companies, provides significant competitor information, analysis, and insight critical to the development and implementation of effective marketing and R&D programs. The report presents a comprehensive analysis of the company's performance, capabilities, goals, and strategies in the global life science intermediates market.Contains 53 pages and 5 tables
|
|
|
$1900.00 |
|
|
|
|
DSM: Performance, Capabilities, Goals and Strategies in the Worldwide Life Science Intermediates Market
A strategies assessment of DSM, one of the world's leading life science intermediates companies, provides significant competitor information, analysis, and insight critical to the development and implementation of effective marketing and R&D programs. The report presents a comprehensive analysis of the company's performance, capabilities, goals, and strategies in the global life science intermediates market.Contains 46 pages and 11 tables
|
|
|
$1900.00 |
|
|
|
|
Evonik: Performance, Capabilities, Goals and Strategies in the Worldwide Life Science Intermediates Market
A strategies assessment of Evonik, one of the world's leading life science intermediates companies, provides significant competitor information, analysis, and insight critical to the development and implementation of effective marketing and R&D programs. The report presents a comprehensive analysis of the company's performance, capabilities, goals, and strategies in the global life science intermediates market.Contains 45 pages and 9 tables
|
|
|
$1900.00 |
|
|
|
|
Lonza: Performance, Capabilities, Goals and Strategies in the Worldwide Life Science Intermediates Market
A strategies assessment of Lonza, one of the world's leading life science intermediates companies, provides significant competitor information, analysis, and insight critical to the development and implementation of effective marketing and R&D programs. The report presents a comprehensive analysis of the company's performance, capabilities, goals, and strategies in the global life science intermediates market.Contains 66 pages and 15 tables
|
|
|
$1900.00 |
|
|
|
|
Novasep: Performance, Capabilities, Goals and Strategies in the Worldwide Life Science Intermediates Market
A strategies assessment of Novasep, one of the world's leading life science intermediates companies, provides significant competitor information, analysis, and insight critical to the development and implementation of effective marketing and R&D programs. The report presents a comprehensive analysis of the company's performance, capabilities, goals, and strategies in the global life science intermediates market.Contains 37 pages and 1 table
|
|
|
$1900.00 |
|
|
|
|
Rhodia: Performance, Capabilities, Goals and Strategies in the Worldwide Life Science Intermediates Market
A strategies assessment of Rhodia, one of the world's leading life science intermediates companies, provides significant competitor information, analysis, and insight critical to the development and implementation of effective marketing and R&D programs. The report presents a comprehensive analysis of the company's performance, capabilities, goals, and strategies in the global life science intermediates market.Contains 63 pages and 7 tables
|
|
|
$1900.00 |
|
|
|
|
|